The objective of present analysis was the confirmation of our previously published data about prognostic value of PD-L1 expression on survival of patients with unresectable NSCLC in stage III that were treated with definitive combined RT and ChT [11]. Here, CD274 is linked to non-small cell lung carcinoma.